Repurposing FDA-approved drugs as potential PARP inhibitors

被引：0
|
作者：
Eznarriaga, Maria [1 ]
Rahman, Taufiq [1 ]
机构：
[1] Univ Cambridge, Cambridge, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2020年 / 177卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P070
引用
收藏
页码：2516 / 2516
页数：1
相关论文
共 50 条
  • [31] Repurposing FDA-approved drugs to combat drug-resistant Acinetobacter baumannii
    Chopra, Sidharth
    Torres-Ortiz, Maria
    Hokama, Leslie
    Madrid, Peter
    Tanga, Mary
    Mortelmans, Kristien
    Kodukula, Krishna
    Galande, Amit K.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (12) : 2598 - 2601
  • [32] A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
    Barrows, Nicholas J.
    Campos, Rafael K.
    Powell, Steven T.
    Prasanth, K. Reddisiva
    Schott-Lerner, Geraldine
    Soto-Acosta, Ruben
    Galarza-Munoz, Gaddiel
    McGrath, Erica L.
    Urrabaz-Garza, Rheanna
    Gao, Junling
    Wu, Ping
    Menon, Ramkumar
    Saade, George
    Fernandez-Salas, Ildefonso
    Rossi, Shannan L.
    Vasilakis, Nikos
    Routh, Andrew
    Bradrick, Shelton S.
    Garcia-Blanco, Mariano A.
    CELL HOST & MICROBE, 2016, 20 (02) : 259 - 270
  • [33] Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae
    Abutaleb, Nader S.
    Elhassanny, Ahmed E. M.
    Nocentini, Alessio
    Hewitt, Chad S.
    Elkashif, Ahmed
    Cooper, Bruce R.
    Supuran, Claudiu T.
    Seleem, Mohamed N.
    Flaherty, Daniel P.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2022, 37 (01) : 51 - 61
  • [34] Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery
    Ray, Abhik Kumar
    Sen Gupta, Parth Sarthi
    Panda, Saroj Kumar
    Biswal, Satyaranjan
    Bhattacharya, Uddipan
    Rana, Malay Kumar
    COMPUTERS IN BIOLOGY AND MEDICINE, 2022, 142
  • [35] Repurposing FDA-Approved Drugs for Eumycetoma Treatment: Homology Modeling and Computational Screening of CYP51 Inhibitors
    Mohamed, Magdi Awadalla
    Awadalla, Mohamed Khalid Alhaj
    Mohamed, Malik Suliman
    Elsaman, Tilal
    Eltayib, Eyman Mohamed
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (01)
  • [36] Safety of FDA-Approved drugs - Reply
    Friedman, MA
    Woodcock, J
    Lumpkin, MM
    Shuren, JE
    Hass, AE
    Thompson, LJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (24): : 2297 - 2298
  • [37] Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection
    Benedict, Ashwini
    Bansal, Neha
    Senina, Svetlana
    Hooper, Idris
    Lundberg, Lindsay
    de la Fuente, Cynthia
    Narayanan, Aarthi
    Gutting, Bradford
    Kehn-Hall, Kylene
    FRONTIERS IN MICROBIOLOGY, 2015, 6
  • [38] NONAPPROVED USES OF FDA-APPROVED DRUGS
    ANDERSON, BJ
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1970, 211 (10): : 1705 - &
  • [39] Repurposing FDA-approved drugs as FXR agonists: a structure based in silico pharmacological study
    Jose, Sandra
    Devi, Sreevidya S.
    Sajeev, Anjana
    Girisa, Sosmitha
    Alqahtani, Mohammed S.
    Abbas, Mohamed
    Alshammari, Abdulrahman
    Sethi, Gautam
    Kunnumakkara, Ajaikumar B.
    BIOSCIENCE REPORTS, 2023, 43 (03)
  • [40] An analysis of FDA-approved drugs for oncology
    Kinch, Michael S.
    DRUG DISCOVERY TODAY, 2014, 19 (12) : 1831 - 1835
12345